Labconco® Expands CentriVap™ Line with New Pro Models, Enhanced Features
April 15, 2025
KANSAS CITY, Missouri – Labconco® Expands CentriVap™ Line with New Pro Models, Enhanced Features Labconco Corporation unveils the redesigned CentriVap™ Pro Centrifugal Concentrator, a breakthrough in speed, precision and efficiency for sample concentration. With this launch, Labconco expands the CentriVap portfolio to include both the advanced Pro models and standard models, offering laboratories flexibility in [...]
SCIEX Appoints Chris Hagen as President
April 14, 2025
FRAMINGHAM, Mass. -- SCIEX, a global leader in life science analytical technologies, announces Chris Hagen as President, effective immediately. Hagen joins SCIEX from Beckman Coulter Diagnostics, a fellow Danaher operating company, where he most recently served as Senior Vice President and General Manager of Core Lab Specialty Solutions. As President of SCIEX, Hagen aims to [...]
April 14, 2025
Three new innovative instrument launches expand reach into further lab segments and sample preparation customers as QIAGEN strengthens market-leading position QIAsymphony Connect set to start phased launch in 2025, first customer sessions being held to highlight enhanced capabilities for oncology and genomics workflows QIAsprint and QIAmini on track for 2026 launches, expanding options for high- [...]
April 14, 2025
MILPITAS, Calif. -- Applied StemCell, an advanced therapeutics CRO/CDMO specializing in iPSCs, gene editing, and small animal models, announced today that it has submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for its ActiCells™ GMP Human Induced Pluripotent Stem Cell (hiPSC) line. This milestone underscores the company’s [...]
April 14, 2025
First-of-its-kind bench scale bioreactor enabling productivity, scalability and efficiency supporting reduced environmental impact WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the 5L DynaDrive Single-Use Bioreactor (S.U.B.), designed to meet the evolving needs of modern bioprocessing. The 5L DynaDrive expands the company's robust portfolio of bioreactors, offering seamless [...]
Oxford Nanopore expands Compatible Products Programme and strengthens multi-omics ecosystem
April 13, 2025
Multiple new partnerships with approved products announced to support broader access to flexible, end-to-end sequencing applications Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now integrate seamlessly with Oxford Nanopore’s rapid, information-rich, accessible and affordable molecular sensing technology. First launched in [...]
April 13, 2025
SHENZHEN, China -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, proudly marks a decade since the commercialization of its proprietary DNBSEQ™ sequencing technology. Over the past ten years, DNBSEQ™ has transformed the landscape of genomics by delivering high-performance, cost-effective sequencing solutions that empower scientists, [...]
April 11, 2025
BRIDGEWATER, N.J. -- Hamamatsu Photonics, a global leader in whole slide imaging and spatial proteomics solutions, is pleased to announce a strategic partnership with Sirona Dx (SDX) as its Technology Access Partner. This collaboration will streamline the technology evaluation process by providing customers with access to deep spatial biology expertise within a GCLP / CLIA accredited [...]
Zymo Research Launches Research Grant to Empower Mapping the RNome
April 10, 2025
Irvine, CA – Zymo Research is proud to introduce the RNome Disruptive Research Grant, that is designed to empower scientists mapping the RNome and advance our overall understanding of RNA. Aligned with the Human RNome Project’s vision, this grant supports researchers exploring the complexities of RNA across all organisms. By fostering collaboration and innovation, Zymo [...]
Harvard Bioscience Announces CFO Transition
April 10, 2025
HOLLISTON, Mass. -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. Cote’s resignation will be effective upon the filing of the Company’s Quarterly Report on Form 10-Q, which is expected to be filed on or before May 12, 2025. The Company [...]

